
FRANCE - Siparex Croissance clocks up good performance for 2005
Sigefi Private Equity’s listed private equity vehicle, Siparex Croissance, has today announced its performance in 2005. The fund, which is quoted on Eurolist’s C compartment, recorded its best performance in five years for parent company net income - amounting to EUR 8.9m, versus EUR 7.8m in 2004 and EUR 5.1m in 2003. Net capital gains for the year rose by 27% to EUR 15.5m. Consolidated net income, calculated according to IFRS standards, totalled EUR 8.4m, versus EUR 14.7m in 2004. IFRS net income in 2004 benefited from exit prices greater than the valuations on 31 December 2003, with a difference of EUR 6.9m, as well as a EUR 9.3m increase in unrealised capital gains. Of that amount, EUR 7.8m was realised during the course of 2005 and was not reflected in IFRS net income for that year. Nevertheless, the value of the portfolio increased by EUR 7.7m in 2005, after additions to allowances.
The shareholders’ meeting on 25 April 2006 will be asked to distribute a dividend of EUR 8.5m, representing virtually all parent company income. This dividend of EUR 2.14 per share, or EUR 2.354 for shares eligible for the loyalty bonus, is 40% higher than for 2004. This change reflects both the 22% increase in the total dividend distribution and the EPS enhancing impact of the January 2006 capital reduction (18%). The pretax yields are 7.23% and 7.95%, respectively, regarding the 27 February 2006 share price.
Thanks to the tax status of SCR venture capital companies, individual shareholders are entitled to receive a tax exemption on dividends, and, for shares acquired since 1 January 2001, on capital gains from disposals. To benefit from this tax treatment, which considerably increases the yield, shareholders must hold their shares for a period of five years and reinvest their dividends in the company during the same period.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater